Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Bone Cee

Approved

STANDARD

Bone Cee

SCHEELE LABORATORIES PHILS., INC.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 48ca706264e2c24f
Company: SCHEELE LABORATORIES PHILS., INC.
Type: Standard

Approval Details

Approval Id: 48ca706264e2c24f
Drug Approval Philippines Name: Bone Cee
Product Name: Bone Cee
Registration Number: HRP-156
Brand Name: Bone Cee
Generic Name: Calcium Ascorbate
Dosage Form: Capsule
Dosage Strength: 605.12mg
Manufacturer: SCHEELE LABORATORIES PHILS., INC.
Issuance Date: 24 May 2023
Expiry Date: 03 October 2026
Pharmacologic Category: Vitamin
Classification: Household Remedy (HR)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

48ca706264e2c24f

Type

Standard

Back to Philippines FDA Approvals

Bone Cee - Philippines FDA Drug Approval Details